Development and Optimization of Tacrolimus-Loaded Solid Lipid Nanoparticle Gels Using a Box–Behnken Design: Comparison of Three Lipid Matrices and In Vivo Evaluation
Open Access
- 4 November 2026
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (11) , 1433
Abstract
Background/Objectives: Tacrolimus has poor aqueous solubility and limited skin permeation, necessitating formulation strategies for effective topical therapy. This study aimed to develop tacrolimus-loaded solid lipid nanoparticles (SLNs) and an SLN-gel, comparing optimized SLNs prepared with three lipids—Compritol 888 ATO (C888), Compritol HD5 ATO (CHD5), and Stearic acid (St.a). Methods: Each SLN was optimized via Box–Behnken design (BBD) using factors X1 (lipid amount), X2 (surfactant amount), and X3 (homogenization speed). Morphological analysis was conducted using SEM and TEM, while the solid-state properties were evaluated by XRD and FT-IR. In vitro drug release was assessed using the dialysis bag method, and permeation was evaluated using Franz diffusion cells. The SLNs showing the highest cumulative permeation with a consistent release profile were tested in a 1-chloro-2,4-dinitrobenzene (DNCB)-induced atopic dermatitis mouse model. Results: Optimized SLNs obtained from the BBD demonstrated particle sizes of 275.8, 190.9, 308.9 nm, PDIs of 0.35, 0.26, 0.14, zeta potentials of −15.2, −12.9, −24.0 mV, and encapsulation efficiencies of 84.6, 91.8, 92.5% for C888, CHD5, and St.a, respectively. In dialysis-bag studies, all SLNs showed higher cumulative release than drug solution and Protopic® 0.1%. SEM/TEM revealed spherical morphology, while FT-IR/XRD confirmed drug incorporation within the lipid matrix. Franz diffusion showed higher permeation than API-gel and Protopic® 0.1%, ranked St.a > C888 > CHD5, with 48 h cumulative amounts of 127.2, 96.8, 87.5 μg/cm2. The St.a-SLN-gel significantly improved atopic dermatitis lesions in the DNCB-induced mouse model in vivo (score 14.5→1.75, n = 6, p < 0.001). Conclusions: Box–Behnken optimization produced an SLN-gel surpassing existing formulations in release, permeation, and in vivo efficacy, demonstrating tunable performance via lipid selection and offering a reproducible, translatable approach for topical tacrolimus.Keywords
Funding Information
- National Research Foundation of Korea
- National Research Foundation of Korea (RS-2024-00360828)
This publication has 68 references indexed in Scilit:
- Codium fragile extract prevents atopic dermatitis in DNCB-induced miceFood Science and Biotechnology, 2024
- Synchrotron-based infrared microspectroscopy of polymeric nanoparticles and skin: Unveiling molecular interactions to enhance permeationChemistry and Physics of Lipids, 2022
- Lipid Nanoparticles for Drug DeliveryAdvanced NanoBiomed Research, 2021
- Encapsulation challenges, the substantial issue in solid lipid nanoparticles characterizationJournal of Cellular Biochemistry, 2017
- The design of naproxen solid lipid nanoparticles to target skin layersColloids and Surfaces B: Biointerfaces, 2016
- Preparation and in vitro study of lipid nanoparticles encapsulating drug loaded montmorillonite for ocular deliveryApplied Clay Science, 2016
- Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): High pressure homogenization versus ultrasoundColloids and Surfaces B: Biointerfaces, 2011
- Efficiency of Fatty Acids as Chemical Penetration Enhancers: Mechanisms and Structure Enhancement RelationshipPharmaceutical Research, 2009
- Box-Behnken design: An alternative for the optimization of analytical methodsAnalytica Chimica Acta, 2007
- Effect of Solid Lipid Nanoparticles Formulation Compositions on Their Size, Zeta Potential and Potential for In Vitro pHIS-HIV-Hugag TransfectionPharmaceutical Research, 2007